BiotechTube
MediPrint Ophthalmics

MediPrint Ophthalmics

San Diego, United States· Est.
mediprintlens.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MediPrint Ophthalmics is a private, clinical-stage biotech company addressing significant unmet needs in ophthalmology through its proprietary MediPrint™ contact lens drug delivery platform. The company has completed a Phase 2a study and is advancing its lead glaucoma program into Phase 2b, with a pipeline targeting multi-billion dollar markets. With a clear path to Phase 3 data and a focus on non-invasive, patient-friendly therapies, MediPrint aims to establish a new standard of care in ocular drug delivery.

GlaucomaDry Eye DiseaseOcular Allergy

Technology Platform

Proprietary MediPrint™ process for printing drug-containing ink onto contact lenses to create sustained-release, drug-eluting lenses.

Opportunities

The company targets multi-billion dollar markets in glaucoma and dry eye disease with a solution that directly addresses poor patient compliance and low drug bioavailability associated with eye drops.
Its platform technology allows for a pipeline of products using already-approved drugs, potentially reducing regulatory risk and development time.

Risk Factors

Key risks include clinical trial failure in ongoing Phase 2b/3 studies, challenges in scaling the proprietary manufacturing process, and future competition from other sustained-release ocular drug delivery technologies.
As a pre-revenue company, it also faces financing risk and dependence on raising additional capital.

Competitive Landscape

MediPrint competes with traditional eye drop manufacturers and other novel drug delivery companies developing inserts, implants, and punctal plugs. Direct competitors in the drug-eluting contact lens space include companies like Johnson & Johnson (Acuvue Theravision) and other smaller biotechs, though MediPrint's proprietary printing process is a key differentiator.

More companies in Drug Delivery & Formulation →More companies in United States →